Published in BMC Med Res Methodol on March 23, 2012
Individual participant data meta-analysis for a binary outcome: one-stage or two-stage? PLoS One (2013) 1.34
Multivariate meta-analysis using individual participant data. Res Synth Methods (2014) 0.94
Get real in individual participant data (IPD) meta-analysis: a review of the methodology. Res Synth Methods (2015) 0.93
Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ. Stat Med (2016) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med (1998) 19.07
How should meta-regression analyses be undertaken and interpreted? Stat Med (2002) 8.96
ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group. Stat Med (1999) 7.32
A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc (2009) 5.81
Calculating the number needed to treat for trials where the outcome is time to an event. BMJ (1999) 5.06
Generating survival times to simulate Cox proportional hazards models. Stat Med (2005) 4.87
Interpretation of random effects meta-analyses. BMJ (2011) 4.32
Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies. Int J Epidemiol (2010) 3.97
Aggregate data meta-analysis with time-to-event outcomes. Stat Med (2002) 3.63
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials (2005) 3.19
How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med (2005) 2.95
A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol (2002) 2.57
Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med (2002) 2.49
A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Stat Med (2000) 2.06
Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future. Br J Cancer (2003) 1.92
Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes. Stat Med (2005) 1.86
Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey. BMJ (2012) 1.80
Iterative generalized least squares for meta-analysis of survival data at multiple times. Biometrics (1994) 1.74
Meta-analysis of summary survival curve data. Stat Med (2008) 1.71
Life tables with concomitant information. Biometrics (1976) 1.65
Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Stat Med (2008) 1.65
Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension (2005) 1.41
The obesity-survival paradox in hemodialysis patients: why do overweight hemodialysis patients live longer? Nutr Clin Pract (2007) 1.38
Meta-analysis of pairs of survival curves under heterogeneity: a Poisson correlated gamma-frailty approach. Stat Med (2009) 1.21
A Bayesian approach to jointly estimate centre and treatment by centre heterogeneity in a proportional hazards model. Stat Med (2005) 1.09
Additive and multiplicative covariate regression models for relative survival incorporating fractional polynomials for time-dependent effects. Stat Med (2005) 1.09
Meta-analysis of a binary outcome using individual participant data and aggregate data. Res Synth Methods (2010) 1.06
Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach. Stat Med (2008) 1.03
Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses. J Clin Epidemiol (2005) 0.91
Investigating centre effects in a multi-centre clinical trial of superficial bladder cancer. Stat Med (1999) 0.90
One-stage parametric meta-analysis of time-to-event outcomes. Stat Med (2010) 0.89
Identification of risk factors in hypertensive patients: contribution of randomized controlled trials through an individual patient database. Circulation (1999) 0.80
Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10
Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA (2011) 8.83
Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med (2009) 7.24
Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation (2006) 7.01
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet (2009) 6.25
Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA (2008) 6.07
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med (2004) 5.67
Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ (2010) 5.60
Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet (2007) 5.21
Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension (2005) 5.05
Pharmacotherapy for mild hypertension. Cochrane Database Syst Rev (2012) 4.66
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet (2010) 3.75
The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med (2002) 3.61
Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension (2007) 3.57
Ten steps towards improving prognosis research. BMJ (2009) 3.44
Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens (2002) 3.43
Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension (2006) 3.42
Telomere length and possible link to X chromosome. Lancet (2004) 3.36
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32
Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med (2013) 3.13
Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) (2013) 2.94
Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension (2013) 2.89
Environmental exposure to cadmium and risk of cancer: a prospective population-based study. Lancet Oncol (2006) 2.88
Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens (2014) 2.82
FTO genotype is associated with phenotypic variability of body mass index. Nature (2012) 2.77
Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension (2010) 2.64
Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ (2008) 2.63
Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation (2007) 2.59
Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertension (2005) 2.54
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia. Blood (2014) 2.53
Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med (2012) 2.52
Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials. J Hypertens (2010) 2.49
Obesity is associated with increased arterial stiffness from adolescence until old age. J Hypertens (2005) 2.47
European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit (2010) 2.42
Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension (2011) 2.33
Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ (2013) 2.31
Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens (2010) 2.28
Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet (2003) 2.27
Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens (2007) 2.26
Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension (2006) 2.19
Bivariate random-effects meta-analysis and the estimation of between-study correlation. BMC Med Res Methodol (2007) 2.13
Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke (2009) 2.13
Hypertension control in community health centers across China: analysis of antihypertensive drug treatment patterns. Am J Hypertens (2013) 2.08
Predictive role of the nighttime blood pressure. Hypertension (2010) 2.07
Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. Neurology (2012) 2.06
Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail (2009) 2.03
Does white coat hypertension require treatment over age 80?: Results of the hypertension in the very elderly trial ambulatory blood pressure side project. Hypertension (2012) 2.03
Sexual maturation in relation to polychlorinated aromatic hydrocarbons: Sharpe and Skakkebaek's hypothesis revisited. Environ Health Perspect (2002) 2.03
Screening and cervical cancer cure: population based cohort study. BMJ (2012) 1.99
Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension (2014) 1.97
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med (2012) 1.90
Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension (2011) 1.89
Standard requirements for GCP-compliant data management in multinational clinical trials. Trials (2011) 1.89
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens (2004) 1.87
Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens (2003) 1.83
Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey. BMJ (2012) 1.80
Essential hypertension. Lancet (2003) 1.79
Self-measured versus ambulatory blood pressure in the diagnosis of hypertension. J Hypertens (2003) 1.78
On-treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med (2007) 1.75
Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens (2003) 1.74
Meta-analysis of genetic studies using Mendelian randomization--a multivariate approach. Stat Med (2005) 1.72
Prognosis research strategy (PROGRESS) 4: stratified medicine research. BMJ (2013) 1.71
Host and environmental determinants of heart rate and heart rate variability in four European populations. J Hypertens (2003) 1.70
A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut (2011) 1.70
Independent relations of left ventricular structure with the 24-hour urinary excretion of sodium and aldosterone. Hypertension (2009) 1.69
Eligibility for renal denervation: experience at 11 European expert centers. Hypertension (2014) 1.68
Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial. J Am Soc Nephrol (2002) 1.68
Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Stat Med (2008) 1.65
The sleep apnea cardiovascular endpoints (SAVE) trial: Rationale and start-up phase. J Thorac Dis (2010) 1.64
An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gbeta3 C825T polymorphism. J Hypertens (2003) 1.64
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature. Hypertens Res (2009) 1.63
The International Database of Ambulatory Blood Pressure in relation to Cardiovascular Outcome (IDACO): protocol and research perspectives. Blood Press Monit (2007) 1.62
Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension (2005) 1.61
A new solar-powered blood pressure measuring device for low-resource settings. Hypertension (2010) 1.61
House dust as possible route of environmental exposure to cadmium and lead in the adult general population. Environ Res (2006) 1.59
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58
Blood pressure and blood selenium: a cross-sectional and longitudinal population study. Eur Heart J (2007) 1.58
Reference values in white Europeans for the arterial pulse wave recorded by means of the SphygmoCor device. Hypertens Res (2006) 1.56
Epistatic interaction between alpha- and gamma-adducin influences peripheral and central pulse pressures in white Europeans. J Hypertens (2005) 1.55
Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects. Am J Hypertens (2004) 1.54
Heterogeneity prevails: the state of clinical trial data management in Europe - results of a survey of ECRIN centres. Trials (2010) 1.53
In-hospital mortality among black patients admitted for hypertension-related disorders in Mbuji Mayi, Congo. Am J Hypertens (2009) 1.52